Genotyping of oral Candida albicans and Candida tropicalis strains in patients with orofacial clefts undergoing surgical rehabilitation by MALDI-TOF MS: Case-series study

Microb Pathog. 2024 Nov:196:106948. doi: 10.1016/j.micpath.2024.106948. Epub 2024 Sep 19.

Abstract

Patients with orofacial clefts are more likely to develop oral fungal diseases due to anatomo-physiological changes and surgical rehabilitation treatment. This case-series study evaluated the genetic diversity and dynamics of oral colonization and spread of C. albicans and C. tropicalis in four patients with orofacial clefts, from the time of hospital admission, perioperative and outpatient follow-up, with specialized physician. Candida biotypes previously identified by CHROMagar Candida and PCR methods were studied by MALDI-TOF MS assays and clustering analyses. Possible correlations with pathogenicity characteristics were observed, including production of hydrolytic exoenzymes and the antifungal sensitivity profiles. Amphotericin B-sensitive and fluconazole-resistant (low frequency) C. tropicalis and C. albicans, including clinically compatible MIC of nystatin, were found in the oral cavity of these patients. Clusters of isolates revealed phenomena of (i) elimination in the operative phase, (ii) maintenance or (iii) acquisition of oral C. tropicalis in the perioperative period and specialized outpatient and medical follow-up. For C. albicans, these phenomena included (i) elimination in the operative phase, (ii) acquisition in the operative phase and propagation from the hospital environment, and (iii) maintenance during hospitalization and operative phase. Amphotericin B and nystatin were shown to be effective in cases of clinical treatment and/or prophylaxis, especially considering the pre-existence of fluconazole-resistant strains. This study confirmed the phenomena of septic maintenance, septic neocolonization and septic elimination involving the opportunistic pathogens. MALDI-TOF MS associated with clustering analysis may assist the monitoring of clinical isolates or groups of epidemiologically important microbial strains in the hospital setting.

Keywords: Candida species; Cluster analysis; MALDI-TOF MS; Orofacial cleft; Pediatric patient.

MeSH terms

  • Adolescent
  • Amphotericin B* / pharmacology
  • Amphotericin B* / therapeutic use
  • Antifungal Agents* / pharmacology
  • Antifungal Agents* / therapeutic use
  • Candida albicans* / drug effects
  • Candida albicans* / genetics
  • Candida albicans* / isolation & purification
  • Candida tropicalis* / drug effects
  • Candida tropicalis* / genetics
  • Candida tropicalis* / isolation & purification
  • Candidiasis, Oral / microbiology
  • Child
  • Child, Preschool
  • Cleft Lip / surgery
  • Cleft Palate / surgery
  • Cluster Analysis
  • Drug Resistance, Fungal*
  • Female
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use
  • Genotype*
  • Humans
  • Male
  • Microbial Sensitivity Tests*
  • Mouth / microbiology
  • Mycological Typing Techniques
  • Nystatin / pharmacology
  • Nystatin / therapeutic use
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization*

Substances

  • Antifungal Agents
  • Amphotericin B
  • Fluconazole
  • Nystatin